What’s in BIOHEMP INTERNATIONAL INC (OTCMKTS:BKIT) After Rise in Shorted Shares?

The stock of BIOHEMP INTERNATIONAL INC (OTCMKTS:BKIT) registered an increase of 37.1% in short interest. BKIT’s total short interest was 25,500 shares in August as published by FINRA. Its up 37.1% from 18,600 shares, reported previously. With 226,400 shares average volume, it will take short sellers 0 days to cover their BKIT’s short positions.

The stock increased 4.00% or $0.005 during the last trading session, reaching $0.13. About 1,000 shares traded. BioHemp International, Inc. (OTCMKTS:BKIT) has 0.00% since August 14, 2018 and is . It has by 0.00% the S&P500.

BioHemp International, Inc. focuses on operating in the fast-growing consumer hemp and cannabidiol market through a strategic rollup of CBD distributors. The company has market cap of $323,317. It focuses on the creation of distribution platform for CBD providers. It currently has negative earnings. The firm was formerly known as Blake Insomnia Therapeutics, Inc. and changed its name to BioHemp International, Inc. in June 2019.

Another recent and important BioHemp International, Inc. (OTCMKTS:BKIT) news was published by Prnewswire.com which published an article titled: “OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of November – PR Newswire” on December 04, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.